Mina Therapeutics Limited
Records under this name other than the patents Mina Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Showing 1 to 6 of 6 · Back to Mina Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,447,773 | Stabilized HNF4A Sarna Compositions and Methods of Use Lapsed on the fee record Ended Sep 20, 2026 · High confidence | Lapsed on the fee record | Ended Sep 20, 2026 | High confidence |
| US 8,835,400 | RNA Molecules That Upregulate Insulin Production Lapsed on the fee record Ended Sep 16, 2026 · Medium confidence | Lapsed on the fee record | Ended Sep 16, 2026 | Medium confidence |
| US 11,365,414 | Methods of inducing insulin production Lapsed on the fee record Ended Jun 21, 2026 · USPTO record | Lapsed on the fee record | Ended Jun 21, 2026 | USPTO record |
| US 9,944,930 | Albumin production and cell proliferation Lapsed on the fee record Ended Apr 17, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 17, 2026 | USPTO record |
| US 9,885,046 | Methods of inducing insulin production Lapsed on the fee record Ended Feb 6, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 6, 2026 | USPTO record |
| US 11,162,099 | HNF4A saRNA compositions and methods of use Lapsed on the fee record Ended Nov 2, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 2, 2025 | USPTO record |